Similar articles for PMID: 28029009

Year	Number of Results
1981	10
1983	2
1985	1
1986	4
1987	2
1989	1
1992	2
1993	1
1995	1
1997	1
1998	3
1999	3
2000	1
2001	1
2003	1
2004	1
2005	1
2006	2
2007	2
2008	1
2009	1
2010	3
2011	2
2012	3
2013	3
2014	12
2015	29
2016	18
2017	33
2018	25
2019	17
2020	9
2021	7
2022	3
2024	0

1

Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria.

Gonzalez MD, McMullen AR, Wallace MA, Crotty MP, Ritchie DJ, Burnham CA. Gonzalez MD, et al. Ann Lab Med. 2017 Mar;37(2):174-176. doi: 10.3343/alm.2017.37.2.174. Ann Lab Med. 2017. PMID: 28029009 Free PMC article. No abstract available.

2

Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

Alatoom A, Elsayed H, Lawlor K, AbdelWareth L, El-Lababidi R, Cardona L, Mooty M, Bonilla MF, Nusair A, Mirza I. Alatoom A, et al. Int J Infect Dis. 2017 Sep;62:39-43. doi: 10.1016/j.ijid.2017.06.007. Epub 2017 Jun 10. Int J Infect Dis. 2017. PMID: 28610832 Free article.

3

Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates.

Humphries RM, Hindler JA, Wong-Beringer A, Miller SA. Humphries RM, et al. Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01858-17. doi: 10.1128/AAC.01858-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28993338 Free PMC article.

4

Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates.

Buehrle DJ, Shields RK, Chen L, Hao B, Press EG, Alkrouk A, Potoski BA, Kreiswirth BN, Clancy CJ, Nguyen MH. Buehrle DJ, et al. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3227-31. doi: 10.1128/AAC.02969-15. Print 2016 May. Antimicrob Agents Chemother. 2016. PMID: 26976862 Free PMC article.

5

Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa.

Shields RK, Clancy CJ, Pasculle AW, Press EG, Haidar G, Hao B, Chen L, Kreiswirth BN, Nguyen MH. Shields RK, et al. J Clin Microbiol. 2018 Jan 24;56(2):e01093-17. doi: 10.1128/JCM.01093-17. Print 2018 Feb. J Clin Microbiol. 2018. PMID: 29167294 Free PMC article.

6

Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.

Zamudio R, Hijazi K, Joshi C, Aitken E, Oggioni MR, Gould IM. Zamudio R, et al. Int J Antimicrob Agents. 2019 Jun;53(6):774-780. doi: 10.1016/j.ijantimicag.2019.02.022. Epub 2019 Mar 2. Int J Antimicrob Agents. 2019. PMID: 30831233

7

Multicenter Evaluation of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Inhibitory Activity against Meropenem-Nonsusceptible Pseudomonas aeruginosa from Blood, Respiratory Tract, and Wounds.

Grupper M, Sutherland C, Nicolau DP. Grupper M, et al. Antimicrob Agents Chemother. 2017 Sep 22;61(10):e00875-17. doi: 10.1128/AAC.00875-17. Print 2017 Oct. Antimicrob Agents Chemother. 2017. PMID: 28739780 Free PMC article.

8

Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.

Sader HS, Castanheira M, Mendes RE, Flamm RK, Farrell DJ, Jones RN. Sader HS, et al. Antimicrob Agents Chemother. 2015;59(6):3656-9. doi: 10.1128/AAC.05024-14. Epub 2015 Apr 6. Antimicrob Agents Chemother. 2015. PMID: 25845861 Free PMC article.

9

In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against clinical isolates of meropenem-non-susceptible Pseudomonas aeruginosa: A two-centre study.

Mirza HC, Hortaç E, Koçak AA, Demirkaya MH, Yayla B, Güçlü AÜ, Başustaoğlu A. Mirza HC, et al. J Glob Antimicrob Resist. 2020 Mar;20:334-338. doi: 10.1016/j.jgar.2019.09.016. Epub 2019 Sep 27. J Glob Antimicrob Resist. 2020. PMID: 31568882 Free article.

10

Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.

Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN. Sader HS, et al. Int J Antimicrob Agents. 2015 Jul;46(1):53-9. doi: 10.1016/j.ijantimicag.2015.02.022. Epub 2015 Apr 14. Int J Antimicrob Agents. 2015. PMID: 25956844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

190 results

Results by year